These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 31880870

  • 1. The use of biologic therapies for the management of pediatric asthma.
    Lovinsky-Desir S.
    Pediatr Pulmonol; 2020 Mar; 55(3):803-808. PubMed ID: 31880870
    [Abstract] [Full Text] [Related]

  • 2. An update on biologic-based therapy in asthma.
    Walsh GM.
    Immunotherapy; 2013 Nov; 5(11):1255-64. PubMed ID: 24188679
    [Abstract] [Full Text] [Related]

  • 3. Selecting the right biologic for your patients with severe asthma.
    Manka LA, Wechsler ME.
    Ann Allergy Asthma Immunol; 2018 Oct; 121(4):406-413. PubMed ID: 30056149
    [Abstract] [Full Text] [Related]

  • 4. Severe asthma: When to resort to biological agents.
    Tenero L, Rossignoli S, Piacentini G.
    Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():37-39. PubMed ID: 32017206
    [Abstract] [Full Text] [Related]

  • 5. [Inflammatory cytokines (IL-4, IL-5 and IL-13)].
    Maeda S, Yanagihara Y.
    Nihon Rinsho; 2001 Oct; 59(10):1894-9. PubMed ID: 11676128
    [Abstract] [Full Text] [Related]

  • 6. Biological treatments for severe asthma: A major advance in asthma care.
    Busse WW.
    Allergol Int; 2019 Apr; 68(2):158-166. PubMed ID: 30792118
    [Abstract] [Full Text] [Related]

  • 7. Anti-IgE and Anti-IL5 Biologic Therapy in the Treatment of Nasal Polyposis: A Systematic Review and Meta-analysis.
    Rivero A, Liang J.
    Ann Otol Rhinol Laryngol; 2017 Nov; 126(11):739-747. PubMed ID: 28918644
    [Abstract] [Full Text] [Related]

  • 8. Severe asthma: what is new in the new millennium.
    Ntontsi P, Samitas K, Zervas E, Gaga M.
    Curr Opin Allergy Clin Immunol; 2020 Apr; 20(2):202-207. PubMed ID: 32004177
    [Abstract] [Full Text] [Related]

  • 9. Biologics for asthma and allergy.
    Walsh GM.
    Curr Opin Otolaryngol Head Neck Surg; 2017 Jun; 25(3):231-234. PubMed ID: 28234780
    [Abstract] [Full Text] [Related]

  • 10. Recent developments in the use of biologics targeting IL-5, IL-4, or IL-13 in severe refractory asthma.
    Walsh GM.
    Expert Rev Respir Med; 2018 Nov; 12(11):957-963. PubMed ID: 30193532
    [Abstract] [Full Text] [Related]

  • 11. Biologic targeted therapy in allergic asthma.
    Bice JB, Leechawengwongs E, Montanaro A.
    Ann Allergy Asthma Immunol; 2014 Feb; 112(2):108-15. PubMed ID: 24468249
    [Abstract] [Full Text] [Related]

  • 12. A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma.
    Bagnasco D, Ferrando M, Varricchi G, Passalacqua G, Canonica GW.
    Int Arch Allergy Immunol; 2016 Feb; 170(2):122-31. PubMed ID: 27637004
    [Abstract] [Full Text] [Related]

  • 13. Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma.
    Peters MC, Wenzel SE.
    Lancet; 2020 Feb 01; 395(10221):371-383. PubMed ID: 32007172
    [Abstract] [Full Text] [Related]

  • 14. Anti-IL-4/-13 based therapy in asthma.
    Walsh GM.
    Expert Opin Emerg Drugs; 2015 Sep 01; 20(3):349-52. PubMed ID: 26021492
    [Abstract] [Full Text] [Related]

  • 15. Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.
    Katsaounou P, Buhl R, Brusselle G, Pfister P, Martínez R, Wahn U, Bousquet J.
    Respir Med; 2019 Apr 01; 150():51-62. PubMed ID: 30961951
    [Abstract] [Full Text] [Related]

  • 16. Biological therapies for eosinophilic asthma.
    Patel SS, Casale TB, Cardet JC.
    Expert Opin Biol Ther; 2018 Jul 01; 18(7):747-754. PubMed ID: 29938543
    [Abstract] [Full Text] [Related]

  • 17. Severe Eosinophilic Allergic Asthma Responsive to Mepolizumab After Failure of 2 Consecutive Biologics.
    Sánchez-Jareño M, Barranco P, Romero D, Domínguez-Ortega J, Quirce S.
    J Investig Allergol Clin Immunol; 2019 Feb 01; 29(1):79-81. PubMed ID: 30785114
    [No Abstract] [Full Text] [Related]

  • 18. Choice of biologics in asthma endotypes.
    Wangberg H, Woessner K.
    Curr Opin Allergy Clin Immunol; 2021 Feb 01; 21(1):79-85. PubMed ID: 33306486
    [Abstract] [Full Text] [Related]

  • 19. Omalizumab in the Therapy of Pediatric Asthma.
    Poddighe D, Brambilla I, Licari A, Marseglia GL.
    Recent Pat Inflamm Allergy Drug Discov; 2018 Feb 01; 12(2):103-109. PubMed ID: 29714140
    [Abstract] [Full Text] [Related]

  • 20. Biologic and New Therapies in Asthma.
    Tabatabaian F, Ledford DK, Casale TB.
    Immunol Allergy Clin North Am; 2017 May 01; 37(2):329-343. PubMed ID: 28366480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.